https://crstoday.com/news/aldeyra-therapeutics-presents-dry-eye-disease-phase-2a-clinical-trial-results-at-arvo/2480191/daily0.7https://crstoday.com/news/johnson-johnson-vision-presents-new-data-on-silicone-hydrogel-contact-lens-muco-adhesive-properties/2480192/daily0.7https://crstoday.com/news/lighthouse-guild-behavioral-programs-focus-on-the-psychological-impact-of-vision-loss-traumatic-brain-injury-and-other-disabilities/2480194/daily0.7https://crstoday.com/news/jj-vision-introduces-artificial-intelligence-powered-virtual-assistant-for-contact-lenses/2480195/daily0.7https://crstoday.com/news/allergan-ceo-large-deal-would-be-an-unlikely-outcome-of-review/2480196/daily0.7https://crstoday.com/news/aerie-announces-us-launch-of-rhopressa/2480197/daily0.7https://crstoday.com/news/usc-roski-eye-institute-scientists-present-latest-research-at-the-arvo-annual-meeting/2480198/daily0.7https://crstoday.com/news/bausch-lomb-will-present-scientific-and-clinical-research-during-arvo-meeing/2480199/daily0.7https://crstoday.com/news/johnson-johnson-vision-highlights-new-data-at-2018-arvo-annual-meeting/2480201/daily0.7https://crstoday.com/news/allergan-presents-data-at-the-arvo-annual-meeting-in-honolulu/2480202/daily0.7https://crstoday.com/news/eyeprint-prosthetics-announces-clinical-outcomes-achieved-with-eyeprintpro/2480203/daily0.7https://crstoday.com/news/hill-rom-enhances-spot-vision-screener-to-serve-senior-population/2480205/daily0.7https://crstoday.com/news/blanchard-announces-notching-technology-for-the-onefit-family-of-scleral-lenses-control-peripheral-recess/2480206/daily0.7https://crstoday.com/news/first-clinical-uses-of-medineering-robotic-endoscopy/2480207/daily0.7https://crstoday.com/news/novaliq-to-present-scientific-and-clinical-research-during-the-2018-arvo-meeting-in-honolulu/2480208/daily0.7https://crstoday.com/news/novartis-launches-app-to-collect-patient-data-in-studies-for-ophthalmic-diseases/2480209/daily0.7https://crstoday.com/news/iantechs-miloop-grabs-two-best-paper-of-session-wins-at-the-ascrs-asoa-annual-meeting/2480210/daily0.7https://crstoday.com/news/market-scope-chinas-ophthalmic-market-to-grow-11-3-to-4-5-billion-in-2023/2480211/daily0.7https://crstoday.com/news/checkedup-announces-content-licensing-initiative-with-the-american-academy-of-ophthalmology-to-strengthen-its-patient-education-offerings/2480213/daily0.7https://crstoday.com/news/akorn-asks-delaware-court-to-require-fresenius-kabi-to-fulfill-its-obligations-under-merger-agreement/2480214/daily0.7https://crstoday.com/news/camras-vision-announces-completion-of-5-7-million-financing-for-novel-glaucoma-device/2480215/daily0.7https://crstoday.com/news/new-csp-report-for-the-oculus-pentacam/2480216/daily0.7https://crstoday.com/news/fresenius-kabi-terminates-4-3-billion-merger-agreement-with-akorn/2480219/daily0.7https://crstoday.com/news/eyecare-partners-moves-into-cincinnati-with-acquisition-of-mariemont-eyecare/2480220/daily0.7https://crstoday.com/news/tfos-recognizes-the-bioprotectant-properties-of-trehalose-a-component-of-thealoz-duo-in-the-treatment-of-dry-eye/2480223/daily0.7https://crstoday.com/news/novartis-confirms-2018-targets-as-alcon-recovery-gains-steam/2480224/daily0.7https://crstoday.com/news/allergan-moves-in-as-shire-rebuffs-63-billion-takeda-bid/2480225/daily0.7https://crstoday.com/news/omeros-omidria-demonstrates-benefits-across-traditional-and-femtosecond-laser-assisted-cataract-surgery-and-in-ifis-cases/2480226/daily0.7https://crstoday.com/news/nations-ophthalmologists-remind-congress-of-the-importance-of-medical-and-surgical-eye-care/2480227/daily0.7https://crstoday.com/news/nine-members-of-congress-honored-for-efforts-to-preserve-access-to-quality-medical-eye-care/2480228/daily0.7https://crstoday.com/news/eyepoint-pharmaceuticals-yutiq-for-posterior-segment-uveitis-to-be-presented-at-the-2018-arvo-annual-meeting/2480232/daily0.7https://crstoday.com/news/optimo-medical-receives-ce-mark-for-optimeyes-surgical-planning-tool/2480233/daily0.7https://crstoday.com/news/alcon-adds-new-gemstone-collection-to-air-optix-colors-lens-portfolio-and-introduces-2-count-packs/2480236/daily0.7https://crstoday.com/news/shire-announces-sale-of-oncology-business-to-servier-for-2-4-billion/2480237/daily0.7https://crstoday.com/news/ivantis-announces-results-of-comparative-migs-clinical-trial/2480238/daily0.7https://crstoday.com/news/aerie-pharmaceuticals-joins-the-ascrs-foundation-in-raising-funds-to-provide-eye-care-for-the-worlds-neediest-patients/2480240/daily0.7https://crstoday.com/news/study-shows-no-benefit-from-fatty-acid-supplements-in-dry-eye/2480241/daily0.7https://crstoday.com/news/alcon-launches-new-technological-enhancements-to-the-lensx-laser/2480242/daily0.7https://crstoday.com/news/glaukos-files-patent-infringement-lawsuit-against-ivantis/2480243/daily0.7https://crstoday.com/news/zeiss-presents-diagnostic-and-surgical-advancements-at-ascrs/2480244/daily0.7https://crstoday.com/news/alcon-introduces-preloaded-delivery-system-for-the-cypass-micro-stent/2480245/daily0.7https://crstoday.com/news/omeros-announces-upcoming-presentations-of-new-data-on-omidria-at-the-ascrs-meeting/2480246/daily0.7https://crstoday.com/news/genetically-modified-cornea-safely-and-effectively-prevents-rejection-post-transplantation/2480247/daily0.7https://crstoday.com/news/omidria-added-to-veterans-health-administration-national-formulary/2480248/daily0.7https://crstoday.com/news/new-data-from-the-horizon-trial-of-the-hydrus-microstent-shows-lower-iop-and-medication-use/2480249/daily0.7https://crstoday.com/news/allergan-announces-launch-of-the-truetear-intranasal-neurostimulation-device-at-ascrs/2480250/daily0.7https://crstoday.com/news/thomas-w-samuelson-md-named-2018-ascrs-president/2480251/daily0.7https://crstoday.com/news/eyepoint-pharmaceuticals-strengthens-global-ip-with-notices-of-allowance-for-two-u-s-patents-related-to-dexycu/2480252/daily0.7https://crstoday.com/news/ellexs-patented-glaucoma-treatment-technologies-to-be-spotlighted-at-ascrs/2480253/daily0.7https://crstoday.com/news/aerie-pharmaceuticals-announces-appointment-of-scott-laranjo-as-director-marketing-roclatan/2480254/daily0.7https://crstoday.com/news/seri-lugano-paracel-riboflavin-selected-by-fda-for-epi-on-cross-linking-for-keratoconus/2480255/daily0.7https://crstoday.com/news/fda-permits-marketing-of-ai-based-device-to-detect-certain-diabetes-related-eye-problems/2480256/daily0.7https://crstoday.com/news/swiss-advanced-vision-launches-active-iol-concept-with-real-time-autofocus/2480257/daily0.7https://crstoday.com/news/lensar-laser-system-receives-fda-clearance-to-perform-corneal-pockets-and-flaps-for-corneal-inlay-procedures/2480258/daily0.7https://crstoday.com/news/alcon-to-present-robust-clinical-program-new-innovations-at-ascrs/2480259/daily0.7https://crstoday.com/news/veteran-business-development-executive-joins-lions-eye-institute-as-cmo/2480260/daily0.7https://crstoday.com/news/bausch-lomb-to-showcase-latest-innovations-new-scientific-data-during-ascrs/2480261/daily0.7https://crstoday.com/news/alcon-introduces-systane-complete-solution-for-dry-eye/2480262/daily0.7https://crstoday.com/news/sifi-announces-approval-of-mini-well-ready-iol-in-singapore/2480263/daily0.7https://crstoday.com/news/johnson-johnson-vision-announces-contact-lens-innovation-with-acuvue-oasys-with-transitions-light-intelligent-technology/2480264/daily0.7https://crstoday.com/news/rayner-set-to-launch-600c-monofocal-aspheric-iol-in-us-at-ascrs/2480265/daily0.7https://crstoday.com/news/imprimis-to-feature-its-cyclosporine-chondroitin-sulfate-and-non-opioid-mko-melt-formulations-at-the-upcoming-ascrs-meeting/2480266/daily0.7https://crstoday.com/news/dallas-lighthouse-for-the-blind-to-merge-with-envision/2480267/daily0.7https://crstoday.com/news/patient-demand-for-better-vision-will-drive-double-digit-growth-in-iol-revenues/2480268/daily0.7https://crstoday.com/news/sightlife-surgical-to-acquire-the-kamra-inlay/2480269/daily0.7https://crstoday.com/news/zepto-receives-award-for-best-capsulotomy-technology-2017/2480270/daily0.7https://crstoday.com/news/fda-issues-warning-letter-to-imprimis-for-false-and-misleading-claims/2480271/daily0.7https://crstoday.com/news/global-dry-eye-treatment-revenues-to-grow-to-49-billion-by-2022/2480272/daily0.7https://crstoday.com/news/xiidra-approved-by-health-canada-to-treat-the-signs-and-symptoms-of-dry-eye-disease/2480273/daily0.7